Nelms Angela Gill's most recent trade in RenovoRx Inc was a trade of 125,132 Stock Option done . Disclosure was reported to the exchange on Jan. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RenovoRx Inc | Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 125,132 | 125,132 | - | - | Stock Option | |
RenovoRx Inc | Nelms Angela Gill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 33,768 | 33,768 | - | - | Stock Option | |
RenovoRx Inc | Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 32,500 | 32,500 | - | - | Employee Stock Option (right to buy) | |
RenovoRx Inc | Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 274,230 | 274,230 | - | - | Employee Stock Option (right to buy) |